Overexpression of mitogen-activated protein kinase superfamily proteins unrelated to Ras and AF-1 of estrogen receptor alpha mutation in advanced stage human breast cancer

Pathology Research and Practice

Volumn 196, Issue 12, 2000, Pages 817-826

  Hori, Masao ^a   Inagawa, Satoshi ^a   Shimazaki, Jiro ^a   Itabashi, Masayuki ^a   Hori, Mitsuo ^b  

^a IBARAKI PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Activation function 1; Estrogen receptor alpha; Human breast cancer; Mitogen activated protein kinase, ras oncogene

Indexed keywords

ESTROGEN RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE;

ADVANCED CANCER; ARTICLE; BREAST CANCER; CANCER STAGING; CELL TRANSFORMATION; ENZYME ACTIVITY; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; ONCOGENE RAS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; TRANSACTIVATION;

EID: 0034522714     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(00)80081-3     Document Type: Article

References (39)

1. The human CL100 gene encodes a Tyr/Thr-protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopus oocyte extracts
2. Correlation of immunocytochemically demonstrated estrogen receptor distribution and histopathologic features in primary breast cancer
3. Role of the two activating domains of the estrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxy-tamoxifen
4. The ras gene family and human carcinogenesis
5. Ras oncogenes in human cancer: A review
6. Novel steroidal pure antiestrogens
7. Analysis of oncogene alterations in human endometrial carcinoma: Prevalence of ras mutations
8. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation
9. Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus
10. Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy
11. Elevated mitogen-activated protein kinase activity in estrogen-nonresponsive human breast cancer cells
12. Dualleucine zipper-bearing kinase (DLK) activates p46SAPK and p38mapk but not ERK2
13. Ras p21 in breast tissue: Associations with pathology and cellular localisation
14. Inhibition of growth factor-induced differentiation of PC12 cells by microinjection of antibody to ras p21
15. Transcriptional regulation by extra-cellular signals: Mechanisms and specificity
16. A PCR-RFLP method for the detection of activated H-ras oncogene with a point mutation at codon 12 and 61
17. RAS gene mutations in acute and chronic myeloid leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes
18. p21/waf1/cip1 and mdm-2 expression in breast carcinoma patients as related to prognosis
19. Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer
20. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
21. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial
22. rskpathway is required for pseudomonas aeruginosa-induced mucin overproduction in epithelial cells
23. Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis
24. Estrogen receptor messenger RNA splice variants are not involved in antiestrogen resistance in sublines of MCF-7 human breast cancer cells
25. Selective activation of the jnk signaling cascade and c-jun transcriptional activity by the small GTPases rac and cdc42Hs
26. A novel MAP kinase phosphatase: Structure, expression, and regulation
27. RSK
28. Activation of mitogen-activated protein kinase cascades by p21-activated protein kinases in cell-free extracts of Xenopus oocytes
29. Point mutation at codon 12 of the Ki-ras gene in a primary breast carcinoma and the MDA-MB-134 human mammary carcinoma cell line
30. Incidence of activating ras oncogene mutations associated with primary and metastatic human breast cancer
31. Detection of K-ras mutation in normal and malignant colonic tissues by an enriched PCR method
32. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies
33. Preliminary study on oncogene product immunohistochemistry (c-erbB-2, c-myc, ras p21, EGFR) in breast pathology
34. Analysis and cloning of eukaryotic genomic DNA
35. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo
36. A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides
37. Immunocytochemical localization of estrogen receptor in human breast tissue
38. Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1
39. Signal transduction via Ras